GFWA
AVXL icon

Grey Fox Wealth Advisors’s Anavex Life Sciences AVXL Stock Holding History

Grey Fox Wealth Advisors’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-300
Closed -$2.78K – 529
2022
Q4 		$2.78K Buy
+300
New +$3.21K ﹤0.01% 336

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $1.74B AUM 32.48% 1-Year Est. Return

Grey Fox Wealth Advisors's AVXL Position: Q1 2023 in Review

Grey Fox Wealth Advisors sold out of Anavex Life Sciences (AVXL) in Q1 2023, closing a stake of 300 shares — an estimated $2.78K sold.

Grey Fox Wealth Advisors first reported a position in AVXL in Q4 2022 and held it in 1 quarter. The position peaked at $2.78K in Q4 2022. 141 funds tracked by Wall St. Rank hold AVXL as of Q1 2023.

  • Grey Fox Wealth Advisors reported no remaining Anavex Life Sciences position as of Q1 2023 after selling out during the quarter.
  • Grey Fox Wealth Advisors sold 300 Anavex Life Sciences shares in Q1 2023, an estimated $2.78K.
  • Grey Fox Wealth Advisors first reported a position in Anavex Life Sciences in Q4 2022 and held it in 1 quarter.
  • Grey Fox Wealth Advisors's Anavex Life Sciences position peaked at $2.78K in Q4 2022.
  • 141 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2023.

Based on Grey Fox Wealth Advisors's 13F filing for Q1 2023, filed 9 May 2023.